BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 24743428)

  • 21. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.
    Fan JG
    J Dig Dis; 2008 May; 9(2):63-7. PubMed ID: 18419637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers.
    Edens MA; Kuipers F; Stolk RP
    Obes Rev; 2009 Jul; 10(4):412-9. PubMed ID: 19413701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The central role of the non alcoholic fatty liver disease in metabolic syndrome.
    Hurjui DM; Niţă O; Graur LI; Mihalache L; Popescu DS; Graur M
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):425-31. PubMed ID: 23077931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders.
    Lim S; Oh TJ; Koh KK
    Int J Cardiol; 2015 Dec; 201():408-14. PubMed ID: 26310987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of non-alcoholic fatty liver disease in cardiovascular disease.
    Perseghin G
    Dig Dis; 2010; 28(1):210-3. PubMed ID: 20460913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pediatric non-alcoholic fatty liver disease: recent advances and challenges].
    Poggiogalle E; Olivero G; Anania C; Ferraro F; Pacifico L
    Minerva Pediatr; 2010 Dec; 62(6):569-84. PubMed ID: 21042270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo.
    Williams KH; Shackel NA; Gorrell MD; McLennan SV; Twigg SM
    Endocr Rev; 2013 Feb; 34(1):84-129. PubMed ID: 23238855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diets and nonalcoholic fatty liver disease: the good and the bad.
    Asrih M; Jornayvaz FR
    Clin Nutr; 2014 Apr; 33(2):186-90. PubMed ID: 24262589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic fatty liver disease.
    Angulo P
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interactions of nonalcoholic fatty liver disease and cardiovascular diseases.
    Perazzo H; Poynard T; Dufour JF
    Clin Liver Dis; 2014 Feb; 18(1):233-48. PubMed ID: 24274877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications.
    Miele L; Targher G
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1243-5. PubMed ID: 26224399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.
    Villanova N; Moscatiello S; Ramilli S; Bugianesi E; Magalotti D; Vanni E; Zoli M; Marchesini G
    Hepatology; 2005 Aug; 42(2):473-80. PubMed ID: 15981216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance, inflammation, and non-alcoholic fatty liver disease.
    Tilg H; Moschen AR
    Trends Endocrinol Metab; 2008 Dec; 19(10):371-9. PubMed ID: 18929493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander.
    Vanni E; Marengo A; Mezzabotta L; Bugianesi E
    Semin Liver Dis; 2015 Aug; 35(3):236-49. PubMed ID: 26378641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review: The role of insulin resistance in nonalcoholic fatty liver disease.
    Utzschneider KM; Kahn SE
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4753-61. PubMed ID: 16968800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction.
    Mikolasevic I; Racki S; Lukenda V; Pavletic-Persic M; Milic S; Orlic L
    Med Hypotheses; 2014 Jan; 82(1):36-9. PubMed ID: 24280560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first?
    Ahmed MH; Ali A
    Scand J Gastroenterol; 2014 May; 49(5):521-7. PubMed ID: 24646400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
    Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
    Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-Alcoholic Fatty Liver Disease (NAFLD): new challenge for general practitioners and important burden for health authorities?
    Ahmed MH; Abu EO; Byrne CD
    Prim Care Diabetes; 2010 Oct; 4(3):129-37. PubMed ID: 20299294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis.
    Pacana T; Fuchs M
    Clin Liver Dis; 2012 Aug; 16(3):599-613. PubMed ID: 22824483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.